• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钬-166-二乙三胺五乙酸作为血管内近距离治疗的液体源。

Holmium-166-DTPA as a liquid source for endovascular brachytherapy.

作者信息

Hong Young-Don, Park Kyung-Bae, Jang Beom-Su, Choi Sun-Ju, Choi Sang-Moo, Kim Young-Mi

机构信息

RI and Radiation Application Team, Korea Atomic Energy Research Institute, 150 Dukjin-dong, Yuseong-gu, 305-353 Daejeon, Republic of South Korea.

出版信息

Nucl Med Biol. 2002 Nov;29(8):833-9. doi: 10.1016/s0969-8051(02)00329-3.

DOI:10.1016/s0969-8051(02)00329-3
PMID:12453593
Abstract

Liquid radiation sources with beta emitters have advantages of accurate positioning and uniform dose distribution to the vessel walls to prevent the restenosis of coronary artery. As a liquid radiation source, 166Ho-DTPA was prepared and evaluated its in-vivo pharmacokinetic behavior through animal studies.166Ho-DTPA was prepared by simple mixing the Holmium with DTPA at room temperature. The radiolabelling yield was 100% when the DTPA/Holmium molar ratio was >2. Radiolabelling of 166Ho-DTPA was not dependent on the pH range of 1.7-7.5. High radiochemical stability (>98%) was maintained over a period of 6 hours even with a radioactivity ( approximately 11.1 GBq/12 mg of DTPA) stored at room temperature. Biodistribution of 166Ho-DTPA in rats and gamma camera images in rabbits showed that 166Ho-DTPA was quickly excreted via the urinary system. The average of T(max) and T(1/2) of 166Ho-DTPA in the kidneys of rabbits were 3.71 +/- 1.18 min and 9.15 +/- 3.15 min. 166Ho-DTPA is a potential liquid radiation source for radiation brachytherapy to prevent the restenosis of the coronary artery using a liquid-filled balloon.

摘要

含β发射体的液体辐射源具有定位准确、血管壁剂量分布均匀的优点,可预防冠状动脉再狭窄。作为一种液体辐射源,制备了166Ho-DTPA,并通过动物研究评估其体内药代动力学行为。166Ho-DTPA是通过在室温下将钬与DTPA简单混合制备而成。当DTPA/钬摩尔比>2时,放射性标记产率为100%。166Ho-DTPA的放射性标记不依赖于1.7-7.5的pH范围。即使在室温下储存放射性(约11.1 GBq/12 mg DTPA)的情况下,6小时内仍保持高放射化学稳定性(>98%)。166Ho-DTPA在大鼠体内的生物分布及在兔体内的γ相机图像显示,166Ho-DTPA通过泌尿系统迅速排出。166Ho-DTPA在兔肾脏中的T(max)和T(1/2)平均值分别为3.71±1.18分钟和9.15±3.15分钟。166Ho-DTPA是一种潜在的液体辐射源,可用于通过充液球囊进行放射性近距离治疗以预防冠状动脉再狭窄。

相似文献

1
Holmium-166-DTPA as a liquid source for endovascular brachytherapy.钬-166-二乙三胺五乙酸作为血管内近距离治疗的液体源。
Nucl Med Biol. 2002 Nov;29(8):833-9. doi: 10.1016/s0969-8051(02)00329-3.
2
Potential 166Ho radiopharmaceuticals for endovascular radionuclide therapy. II. Preparation and evaluation of 166Ho-DTPA.用于血管内放射性核素治疗的潜在166Ho放射性药物。II. 166Ho-DTPA的制备与评估。
Nucl Med Commun. 2001 Jan;22(1):97-103. doi: 10.1097/00006231-200101000-00014.
3
[166Dy]Dy/166Ho hydroxide macroaggregates: an in vivo generator system for radiation synovectomy.[166镝]镝/166钬氢氧化物大聚集体:用于放射性滑膜切除术的体内发生器系统。
Appl Radiat Isot. 2004 Dec;61(6):1227-33. doi: 10.1016/j.apradiso.2004.04.018.
4
166Ho-coated balloon for vascular brachytherapy.用于血管近距离放射治疗的166钬涂层球囊
Appl Radiat Isot. 2003 Apr;58(4):455-62. doi: 10.1016/s0969-8043(03)00050-2.
5
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.用于骨骼靶向放射治疗的166Ho-DOTMP辐射吸收剂量估计
J Nucl Med. 2006 Mar;47(3):534-42.
6
Labeling of biotin with [166Dy]Dy/166Ho as a stable in vivo generator system.用[166Dy]Dy/166Ho标记生物素作为一种稳定的体内发生器系统。
Int J Pharm. 2003 Apr 14;255(1-2):129-38. doi: 10.1016/s0378-5173(03)00052-8.
7
Preparation and evaluation of [166Ho] holmium-dimethyl diethylenetriaminepentaaceticacid (DMDTPA) as potential radiopharmaceutical for endovascular radiation therapy (EVRT).[166Ho]钬-二甲基二乙三胺五乙酸(DMDTPA)作为血管内放射治疗(EVRT)潜在放射性药物的制备与评估。
Appl Radiat Isot. 2002 Jun;56(6):863-9. doi: 10.1016/s0969-8043(02)00057-x.
8
[166Dy]dysprosium/[166Ho]holmium in vivo generator.[166Dy]镝/[166Ho]钬体内发生器
Appl Radiat Isot. 1995 Aug;46(8):759-64. doi: 10.1016/0969-8043(94)00149-t.
9
Automated preparation of 188Re-labeled radiopharmaceuticals for endovascular radiation therapy.用于血管内放射治疗的188Re标记放射性药物的自动化制备
Appl Radiat Isot. 2003 Oct;59(4):225-30. doi: 10.1016/s0969-8043(03)00170-2.
10
Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice.钬-166-壳聚糖复合物(DW-166HC)在大鼠和小鼠体内的生物分布及动力学
J Nucl Med. 1998 Dec;39(12):2161-6.

引用本文的文献

1
Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.在大型动物模型(尤卡坦小型猪)中向诱导的 U87 神经胶质瘤瘤内递送 165Ho 硅氧烷的可行性。
PLoS One. 2020 Jun 18;15(6):e0234772. doi: 10.1371/journal.pone.0234772. eCollection 2020.
2
The various therapeutic applications of the medical isotope holmium-166: a narrative review.医用同位素钬-166的各种治疗应用:一项叙述性综述。
EJNMMI Radiopharm Chem. 2019 Aug 5;4(1):19. doi: 10.1186/s41181-019-0066-3.
3
Effects of intraluminal irradiation with Holmium-166 for TIPS stenosis: experimental study in a swine model.
钬-166腔内照射治疗经颈静脉肝内门体分流术狭窄的效果:猪模型的实验研究
Korean J Radiol. 2007 Mar-Apr;8(2):127-35. doi: 10.3348/kjr.2007.8.2.127.